Factor | Boerlin_2001_JoofClMi (10251)

Tylosin as an antimcorbial growth promoter

Swine | Not Specified

27

Description

Comparing samples from farms using Tylosin as an antimcorbial growth promoter before and after ban on antimicorbial growth promoters

Resistance Outcomes

Resistance Microbe Outcome
Erythromycin
/
Enterococcus Combination
See: Table 1 AMR+ (%) AMR- (%) Total (n)
Antimicrobial use 1.00 96
no use 32.00 59
Spiramycin
/
Enterococcus Combination
See: Table 1 AMR+ (%) AMR- (%) Total (n)
Antimicrobial use 10.00 96
no use 59.00 59
Clindamycin
/
Enterococcus Combination
See: Table 1 AMR+ (%) AMR- (%) Total (n)
Antimicrobial use 1.00 96
no use 34.00 59
Vancomycin
/
Enterococcus Combination
See: Table 1 AMR+ (%) AMR- (%) Total (n)
Antimicrobial use 98.00 96
no use 97.00 59
Phenoxymethylpenicillin
/
Enterococcus Combination
See: Table 1 AMR+ (%) AMR- (%) Total (n)
Antimicrobial use 84.00 96
no use 90.00 59
Tetracycline
/
Enterococcus Combination
See: Table 1 AMR+ (%) AMR- (%) Total (n)
Antimicrobial use 21.00 96
no use 55.00 59
Chloramphenicol
/
Enterococcus Combination
See: Table 1 AMR+ (%) AMR- (%) Total (n)
Antimicrobial use 88.00 96
no use 88.00 59
Streptomycin
/
Enterococcus Combination
See: Table 1 AMR+ (%) AMR- (%) Total (n)
Antimicrobial use 76.00 96
no use 92.00 59
Gentamicin
/
Enterococcus Combination
See: Table 1 AMR+ (%) AMR- (%) Total (n)
Antimicrobial use 100.00 96
no use 100.00 59
Erythromycin
/
Enterococcus faecium
See: Table 1 AMR+ (%) AMR- (%) Total (n)
Antimicrobial use 0.00 45
no use 4.00 27
Spiramycin
/
Enterococcus faecium
See: Table 1 AMR+ (%) AMR- (%) Total (n)
Antimicrobial use 20.00 45
no use 67.00 27
Clindamycin
/
Enterococcus faecium
See: Table 1 AMR+ (%) AMR- (%) Total (n)
Antimicrobial use 2.00 45
no use 41.00 27
Vancomycin
/
Enterococcus faecium
See: Table 1 AMR+ (%) AMR- (%) Total (n)
Antimicrobial use 96.00 45
no use 93.00 27
Phenoxymethylpenicillin
/
Enterococcus faecium
See: Table 1 AMR+ (%) AMR- (%) Total (n)
Antimicrobial use 69.00 45
no use 82.00 27
Tetracycline
/
Enterococcus faecium
See: Table 1 AMR+ (%) AMR- (%) Total (n)
Antimicrobial use 36.00 45
no use 70.00 27
Chloramphenicol
/
Enterococcus faecium
See: Table 1 AMR+ (%) AMR- (%) Total (n)
Antimicrobial use 87.00 45
no use 100.00 27
Streptomycin
/
Enterococcus faecium
See: Table 1 AMR+ (%) AMR- (%) Total (n)
Antimicrobial use 73.00 45
no use 92.00 27
Gentamicin
/
Enterococcus faecium
See: Table 1 AMR+ (%) AMR- (%) Total (n)
Antimicrobial use 100.00 45
no use 100.00 27
Gentamicin
/
Enterococcus Other
See: Table 1 AMR+ (%) AMR- (%) Total (n)
Antimicrobial use 100.00 39
no use 100.00 24
Erythromycin
/
Enterococcus Other
See: Table 1 AMR+ (%) AMR- (%) Total (n)
Antimicrobial use 0.00 39
no use 71.00 24
Spiramycin
/
Enterococcus Other
See: Table 1 AMR+ (%) AMR- (%) Total (n)
Antimicrobial use 0.00 39
no use 63.00 24
Clindamycin
/
Enterococcus Other
See: Table 1 AMR+ (%) AMR- (%) Total (n)
Antimicrobial use 0.00 39
no use 33.00 24
Vancomycin
/
Enterococcus Other
See: Table 1 AMR+ (%) AMR- (%) Total (n)
Antimicrobial use 100.00 39
no use 100.00 24
Phenoxymethylpenicillin
/
Enterococcus Other
See: Table 1 AMR+ (%) AMR- (%) Total (n)
Antimicrobial use 100.00 39
no use 100.00 24
Tetracycline
/
Enterococcus Other
See: Table 1 AMR+ (%) AMR- (%) Total (n)
Antimicrobial use 5.00 39
no use 33.00 24
Chloramphenicol
/
Enterococcus Other
See: Table 1 AMR+ (%) AMR- (%) Total (n)
Antimicrobial use 87.00 39
no use 79.00 24
Streptomycin
/
Enterococcus Other
See: Table 1 AMR+ (%) AMR- (%) Total (n)
Antimicrobial use 82.00 39
no use 92.00 24